Magic mushroom compound tested as dual treatment for depression and drinking
NCT ID NCT04620759
Summary
This study is testing whether a single dose of psilocybin, the active compound in 'magic mushrooms,' can help people who have both major depression and alcohol use disorder. Researchers at Johns Hopkins are comparing the effects of psilocybin to a placebo in 90 participants. The goal is to see if the treatment leads to lasting reductions in depression symptoms and heavy drinking days.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALCOHOL USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Johns Hopkins Center for Psychedelic and Consciousness Research
Baltimore, Maryland, 21224, United States
Conditions
Explore the condition pages connected to this study.